NOT-CA-10-003: Administrative Supplements for Disseminating Evidence-based Computer-tailored Cancer Control Interventions

Administrative Supplements for Disseminating Evidence-based Computer-tailored Cancer Control Interventions

Notice Number: NOT-CA-10-003

Key Dates
Release Date: November 6, 2009
Request Submission Deadline: January 15, 2010

Issued by
National Cancer Institute (NCI), (http://www.cancer.gov)

Purpose and Objectives

The National Cancer Institute (NCI) announces the availability of administrative supplements to NCI-funded grants for the dissemination of evidence-based computer-tailored interventions and products. “Parent” grants that can be supplemented under this opportunity include only R01, P01, P20, P50, U01, U19, and U54 grants for which statistical significance and potential health/clinical significance suggest the merits of dissemination to a broader population than that from which the intervention study sample was originally drawn. These administrative supplements are designed to provide 1 year (maximum) of additional funding to eligible cancer control investigators who are Principal Investigators on eligible “Parent” grants.

Eligibility

Applicants may request supplemental funding for the qualifying R01, P01, P20, P50, U01, U19, or U54 intervention research awards provided the following conditions are met:

The proposed intervention dissemination must be relevant to the focus of the qualifying “Parent” grant;
The proposed dissemination effort must be beyond the original scope of the Parent grant;
The Parent grant must remain active during the entire funding period of this supplement;
Computer-tailored interventions proposed for dissemination must have already been tested for their efficacy; and
The proposed dissemination effort must be completed within the period of supplemental funding (1 year maximum).

Only the Principal Investigator of the Parent grant may request the supplement.

Intervention research activities that are eligible for these supplements may span diverse areas of cancer control and include projects in areas such as:

Prevention and cessation of tobacco use;
Promotion of appropriate changes in diet and physical activity;
Reduction of sun exposure and ultraviolet (UV) radiation exposure;
Facilitation of informed decisions about genetic testing for cancer susceptibility;
Enhancement of screening programs for breast, cervix, and colorectal cancers;
Development and dissemination of improvements in coping skills and quality-of-life for cancer survivors and their families.

All modes of delivering computer-tailored interventions (print, web-based, mobile devices, etc.) are appropriate for these administrative supplements.

Submitting a Request

Requests for administrative supplements must be prepared and submitted to the NCI as described in detailed instructions posted at http://cancercontrol.cancer.gov/dd_instructions-2009.html. This Notice is a one-time announcement and formal requests must be received on or before January 15, 2010.

Request letters should contain sufficient detail (similar to a standard research application) to allow assessment of the scientific merit of the proposed dissemination plans and the appropriateness of the request for supplemental funding. The evaluation of the scientific merit of the requests will be based on criteria analogous to those used to assess the merit of the original applications that resulted in respective “parent” awards. Scientific merit will be based on five evaluation categories: significance, approach, innovation, investigator and environment.
(See https://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-025.html).

All requests must include an itemized budget. Budget requests must not exceed $150,000 in total costs for a project period of up to 12 months.

Requests for supplements under this program must comply with NIH policies for inclusion of women, minorities, and children in research involving human subjects. All Institutional Review Board (IRB) documentation and site assurances must be submitted to the NCI in the supplement request.

Applications must be signed by the Authorized Organizational Representative (AOR) at the grantee institution.

Request letters will be evaluated by NCI program staff (and appropriate consultants) who have expertise in the cancer control intervention area and/or in dissemination and diffusion research. Supplements will be awarded based on scientific merit, program relevance, and dissemination potential of the proposed interventions as well as on the availability of funds. Special consideration will be given to applications that include plans to disseminate interventions tested in low income and ethnically diverse populations.

Applicants are strongly encouraged to submit requests electronically as an e-mail attachment in pdf format; however, the signature of the AOR must be clearly visible. The e-mail address for electronic submission is: cvinson@mail.nih.gov

Applicants may also submit applications on paper (original and four copies) to:

Cynthia Vinson, M.P.A.
Dissemination and Diffusion Coordinator
Division of Cancer Control and Population Sciences
National Cancer Institute
6130 Executive Boulevard, EPN Room 6140
Bethesda, MD 20892-7338 (for U.S. Postal Service regular or express mail)
Rockville, MD 20852 (for non-USPS delivery)
Telephone: 301-594-5906
E-mail: cvinson@mail.nih.gov

Do not send supplement requests to the NIH Center for Scientific Review.

Anticipated Award Date

The earliest anticipated award date for this program will be May 31, 2010.

Inquiries

Inquiries related to this notice should be addressed to the NCI Program Director for the particular R01, P01, P50, U01, or U19 grant for which the supplement is being requested. Before submitting an application, each applicant (i.e., Principal Investigator) is encouraged to discuss the efficacy data (e.g., effect sizes, consistency with prior research, relevance to target populations) supporting their competing supplement request from the original project with their respective NCI research project Program Director.

Direct inquiries concerning the programmatic and review matters to:

Direct inquiries regarding administrative and financial aspects should be made to:

Crystal Wolfrey
Office of Grants Administration
6120 Executive Boulevard, EPS Room 243
Bethesda, MD 20892-7150 (for U.S. Postal Service regular or express mail)
Rockville, MD 20852 (for non-USPS delivery)
Telephone: 301-496-8634
E-mail: crystal.wolfrey@nih.gov

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.